摘要
目的:研究扁桃体鳞癌(squamous cell carcinomas of the tonsil tonsillar,SCCs)中人乳头瘤病毒(human papillomavirus,HPV)感染与血管内皮生长因子(vascular endothelial growth factor,VEGF)和表皮生长因子受体(epidermal growth factor,EGFR)表达的关系,探讨HPV与EGFR和VEGF在扁桃体鳞癌发生中的交互效应。方法:采用多重实时荧光定量聚合酶链反应(multiplex real-time polymerase chain reaction,MT-PCR)检测85例扁桃体鳞癌HPV DNA及型别,通过HPV DNA分析进行HPV感染状况的测定;同时采用半定量免疫组化检测HPV(+)组和HPV(-)组中VEGF、EGFR蛋白表达情况。结果:扁桃体鳞癌中HPV感染率为49.4%(42/85),HPV-16型占所有感染者的比例为90.5%(38/42),明显高于其他型别;HPV(+)组EGFR蛋白表达明显低于HPV(-)组(P值均<0.01);HPV(+)组与HPV(-)组VEGF蛋白表达无明显差异;此外,VEGF表达与EGFR、患者的年龄、性别、TNM分期、组织学分级均无明显相关性。结论:HPV感染与扁桃体鳞癌的发生存在相关性,HPV相关的扁桃体鳞癌中,HPV基因可能通过改变EGFR表达致癌,为HPV致癌机理进一步研究提供一个新的视角,具有重要的理论意义。
Objective:To study the relationship between human papillomavirus (HPV) infection and the expres- sion of vascular endothelial growth factor(VEGF) , epidermal growth factor(EGFR) in 85 squamous cell carcinomas of the tonsil( tonsillar SCCs). To investigate their significance in the oncogenesis of tonsillar cancer. Methods: HPV status was determined by HPV multiplex real - time polymerase chain reaction( MT - PCR). Expression of VEGF and EGFR in HPV ( + ) and HPV ( - ) group was assessed by semiquantitative immunohistochemistry. Results:The infec- tion rate of HPV in tonsillar SCCs was 49.4% (42/85). The infection rate of HPV - 16 was 90.5% (38/42) in all positive specimens was significantly higher than other HPV types. The expression of EGFR in HPV ( - ) group was significantly higher than that in HPV( + ) group( P 〈 0.01 ). The expression of VEGF had no significant difference between HPV( + ) group and HPV( - ) group. There were no associations between VEGF and EGFR expression, gender, age,TNM stage or histology grade. Conclusion: HPV infection has significant correlation with the oncogenesis of tonsillar SCCs. In HPV - positive tonsillar SCCs, HPV gene may change EGFR expression.
出处
《现代肿瘤医学》
CAS
2015年第4期461-464,共4页
Journal of Modern Oncology
基金
云南省地方公派出国留学基金资助项目(编号:2006022)
关键词
扁桃体癌
鳞状细胞癌
人乳头瘤病毒
血管内皮生长因子
表皮生长因子受体
tonsillar cancer
squamous cell carcinomas
human papillomavirus (HPV)
vascular endothelial growthfactor(VEGF)
epidermal growth factor(EGFR)